GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Samjin Pharmaceutical Co Ltd (XKRX:005500) » Definitions » Price-to-Owner-Earnings

Samjin Pharmaceutical Co (XKRX:005500) Price-to-Owner-Earnings : (As of Jun. 19, 2024)


View and export this data going back to 1988. Start your Free Trial

What is Samjin Pharmaceutical Co Price-to-Owner-Earnings?

As of today (2024-06-19), Samjin Pharmaceutical Co's share price is ₩20350.00. Samjin Pharmaceutical Co does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Samjin Pharmaceutical Co's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Samjin Pharmaceutical Co was 470.78. The lowest was 6.73. And the median was 14.29.


XKRX:005500's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 24.73
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-19), Samjin Pharmaceutical Co's share price is ₩20350.00. Samjin Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩1,125.00. Therefore, Samjin Pharmaceutical Co's PE Ratio for today is 18.09.

As of today (2024-06-19), Samjin Pharmaceutical Co's share price is ₩20350.00. Samjin Pharmaceutical Co's EPS without NRI for the trailing twelve months (TTM) ended in was ₩1,168.56. Therefore, Samjin Pharmaceutical Co's PE Ratio without NRI for today is 17.41.

During the past 13 years, Samjin Pharmaceutical Co's highest PE Ratio without NRI was 499.85. The lowest was 8.45. And the median was 13.68.


Samjin Pharmaceutical Co Price-to-Owner-Earnings Historical Data

The historical data trend for Samjin Pharmaceutical Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samjin Pharmaceutical Co Price-to-Owner-Earnings Chart

Samjin Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.51 33.44 - - -

Samjin Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Samjin Pharmaceutical Co's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Samjin Pharmaceutical Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Samjin Pharmaceutical Co's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Samjin Pharmaceutical Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Samjin Pharmaceutical Co's Price-to-Owner-Earnings falls into.



Samjin Pharmaceutical Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Samjin Pharmaceutical Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=20350.00/-453.83
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Samjin Pharmaceutical Co  (XKRX:005500) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Samjin Pharmaceutical Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Samjin Pharmaceutical Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Samjin Pharmaceutical Co (XKRX:005500) Business Description

Traded in Other Exchanges
N/A
Address
121, Wausan-ro, Mapo-Ku, Seoul, KOR, 121-837
Samjin Pharmaceutical Co Ltd is a part of the healthcare sector in Korea. The company functions as a pharmaceutical product manufacturer addressing severe diseases such as osteoporosis, hepatitis, respiratory and gastrointestinal diseases. Its suite of products includes capsules, syringes, injection medicines, and solvents.

Samjin Pharmaceutical Co (XKRX:005500) Headlines

No Headlines